Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy
Active, not recruiting · NCT03092011 · Registry updated 2024-10-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Neonatal Abstinence Syndrome With Clonidine Versus Morphine as Primary Therapy | Chemically-Induced Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, neonatal abstinence syndrome, psychiatric disorder, substance-related disorder | Active, not recruiting | Phase 4 | 2024-10-15 | NCT03092011 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The Cooper Health System | 18 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cooper University Hospital | Camden | United States | 36 |